Estimating the Daily Milligrams of Morphine Equivalent of Illicit Fentanyl Use in Los Angeles: Clinical and Epidemiological Implications

This study utilizes Los Angeles drug checking data to estimate that individuals consuming illicit fentanyl ingest daily doses equivalent to thousands of milligrams of oral morphine, a magnitude far exceeding clinical guidelines that likely drives high overdose mortality and extreme opioid tolerance.

The Gist

The Big Picture: The "Black Box" of the Drug Supply

Imagine the illegal drug market as a giant, chaotic warehouse where every package is wrapped in mystery. If you buy a bag of "fentanyl," you have no idea what's actually inside. Is it pure? Is it mostly fake? Is it mixed with something else?

For years, doctors and researchers have known that fentanyl is incredibly strong—like a tiny grain of sand that could knock out an elephant. But they didn't know exactly how much people were actually taking every day, or how much "real" drug was in those mystery bags.

This study is like sending a team of detectives into that warehouse to weigh the packages, test the ingredients, and ask the people buying them, "How much of this do you use every day?"

The Investigation: How They Did It

The researchers in Los Angeles partnered with a community program called "Drug Checking." Think of this as a "food safety inspector" for illegal drugs. People bring small samples of their drugs to be tested in a high-tech lab.

1. The Samples: They looked at 509 bags of drugs that people thought were fentanyl.
2. The Lab Test: Using a super-powerful microscope (called Mass Spectrometry), they figured out the purity. It's like checking a bag of "100% chocolate chips" and finding out it's actually only 12% chocolate chips and 88% sugar and flour.
3. The Survey: They asked 47 regular users, "How much of this stuff do you use in a day?" and "How do you take it? (Smoking, injecting, snorting?)"

The Math: Converting the Chaos

To understand the danger, the researchers had to translate everything into a common language doctors use: Morphine Equivalent (MME).

Imagine morphine is the "standard dollar" of painkillers.

• If you take 1 pill of Drug A, it might be worth $10.
• If you take 1 pill of Drug B, it might be worth $100.

Fentanyl is the "super-currency." The researchers calculated that the fentanyl people were using was worth thousands of times more than standard painkillers.

They used a complex computer model (a "bootstrapping" simulation) that ran 1 million times to account for all the guesswork. They asked: What if the purity is low? What if it's high? What if they smoke it vs. inject it?

The Shocking Results

Here is what they found, using a simple analogy:

The "Coffee Cup" Analogy:

• Standard Medical Limit: Doctors usually tell patients not to take more than 90 "units" of painkillers a day. Imagine this is drinking one small cup of coffee.
• The Study's Findings: The average person in this study was consuming the equivalent of 8,887 "units" of painkillers a day.

That is like drinking 98 cups of coffee every single day.

If you drank that much coffee, your heart would likely stop. Yet, these individuals were taking this massive amount of "drug coffee" and surviving (until they didn't).

Why Does This Matter?

This study explains three huge problems in the current overdose crisis:

1. The "Russian Roulette" of Purity
Because the purity varies so wildly (from 0.2% to nearly 40%), one day a bag might be weak, and the next day it might be pure. It's like buying a lottery ticket where the prize is either a candy bar or a nuclear bomb. You never know which one you're getting, leading to accidental overdoses.

2. The "Tolerance Monster"
Because people are taking such massive amounts (the 98 cups of coffee), their bodies build up a huge "tolerance." They need more and more just to feel normal. This is why overdoses happen so easily; the body is constantly fighting to keep up with the massive dose.

3. The "Treatment Gap"
This is the most critical finding for doctors.

• Methadone (a common treatment for addiction) is like a standard cup of coffee.
• The Illicit Fentanyl these people are used to is like a jet engine.

When a doctor tries to start a patient on methadone, the dose they give (maybe 20–40mg) feels like a drop in the ocean compared to what the patient's body is used to. It's like trying to put out a forest fire with a water pistol. The patient feels sick, craves the "jet engine," and often leaves treatment to go back to the street drugs.

The Takeaway

This paper tells us that the "average" dose of illicit fentanyl is astronomically high—orders of magnitude higher than anything doctors ever prescribe.

It's not just that fentanyl is strong; it's that the amount people are consuming is mind-boggling. This explains why so many people are dying and why it is so hard to get them into treatment. To save lives, doctors might need to rethink how they start treatment, perhaps using much higher doses or different strategies to match the "jet engine" power of the drugs people are currently using.

In short: The drug supply has become so potent and unpredictable that the human body is being forced to adapt to levels of drugs that are almost impossible to survive, making the path to recovery incredibly difficult.

Technical Summary

1. Problem Statement

The North American overdose crisis has shifted from heroin to illicitly manufactured fentanyl (IMF), driving a surge in mortality. While fentanyl is known to be significantly more potent than other opioids, there is a critical lack of quantitative data regarding the actual daily doses consumed by individuals with Opioid Use Disorder (OUD) in real-world settings.

• The Gap: Clinical guidelines for chronic pain typically recommend limiting oral morphine equivalents (MME) to 90 mg/day. However, the potency and purity of illicit fentanyl are highly variable, and users are often unaware of the actual drug content or dosage.
• The Challenge: Quantifying exposure is difficult due to the lack of quality control in the illicit market, shifting drug compositions, and the inability to link specific sample purity to individual consumption habits.
• Clinical Impact: This uncertainty complicates the initiation and maintenance of Medications for Opioid Use Disorder (MOUD), such as methadone and buprenorphine, as standard induction doses may be insufficient to manage the extreme tolerance developed from high-potency illicit use.

2. Methodology

The study employed a bootstrapping simulation model to estimate daily MME consumption by integrating community-based drug checking data with self-reported usage patterns and literature-derived pharmacokinetic parameters.

Data Sources:

• Drug Samples: 509 illicit fentanyl samples collected between September 2023 and January 2026 from "Drug Checking Los Angeles" (a community-based harm reduction program).
  • Analysis: Samples were analyzed via Liquid Chromatography Mass Spectrometry (LC-MS) at the National Institute of Standards and Technology (NIST).
  • Purity Definition: Combined weight percentage of fentanyl and fluorofentanyl (assumed equipotent).
• Consumption Survey: Data from 47 respondents who reported regular fentanyl use in the past 30 days.
  • Metrics: Self-reported daily consumption (in grams) and routes of administration (smoking, injection, insufflation, oral).

Modeling Approach:
The study utilized a Monte Carlo simulation with 1,000,000 draws to account for parameter uncertainty. The core equation for Estimated Consumption (MME) was:
$$\text{MME} = \text{Mass Consumed} \times \text{Purity} \times \text{Bioavailability} \times \text{MME Conversion Factor}$$

Parameter Distributions:

1. Mass Consumed: Resampled from the 47 survey respondents (mean ~1.07g raw product/day).
2. Purity: Resampled from the 509 LC-MS results (mean 12.47%).
3. Bioavailability: Derived from literature reviews for specific routes:
   • IV: 80–100% (adjusted for "missed" shots).
   • Smoking/Vaporizing: 30–58% (adjusted for environmental loss based on methamphetamine literature).
   • Intranasal: 50–66%.
   • Oral: ~30%.
   • Note: For users reporting multiple routes, weights were probabilistically assigned.
4. MME Conversion Factor: Derived from literature converting IV fentanyl to Oral Morphine.
   • IV Fentanyl to IV Morphine: 1:33 to 1:100.
   • IV Morphine to Oral Morphine: 1:2 to 1:3.
   • Resulting Range: 1:66 to 1:300 (Mean ~1:183).

Sensitivity Analyses:
To address the unknown correlation between purity and quantity consumed, three scenarios were modeled:

1. Inverse Correlation (Conservative): Assumes users of higher purity consume less raw mass.
2. No Correlation: Assumes purity and quantity are independent.
3. Smoking-Only Bioavailability: Assumes all users smoke, regardless of other reported routes (to test the impact of lower bioavailability estimates).
   The primary result presented is a hybrid model combining the distributions of the inverse and no-correlation scenarios (2,000,000 total draws).

3. Key Results

Descriptive Statistics:

• Daily Consumption: Mean raw product consumption was 1.07 grams (95% PI: 0.03g – 4.00g).
• Purity: Mean fentanyl purity was 12.47% (95% PI: 0.23% – 38.80%).
• Bioavailability: Mean estimated bioavailability across routes was 50.82% (95% PI: 30.64% – 76.75%).
• Conversion Factor: Mean IV fentanyl to PO morphine factor was 1:183.15.

Primary Outcome (Hybrid Model):

• Estimated Daily MME: The mean estimated daily consumption was 8,887.55 MME.
• Prediction Interval: 95% PI ranged from 560.23 MME to 20,917.89 MME.

Sensitivity Analysis Findings:

• Inverse Correlation Scenario: Lowered the mean estimate to 6,007.91 MME.
• No Correlation Scenario: Raised the mean estimate to 11,767.19 MME with a highly skewed distribution (up to 56,137 MME).
• Smoking-Only Scenario: Lowered the mean to 7,739.18 MME due to reduced bioavailability assumptions.
• Conclusion: Under all plausible scenarios, the estimated MME consumption is orders of magnitude higher than clinical norms.

4. Key Contributions

• First Quantification of Real-World MME: This is the first study to quantify the daily MME of illicit fentanyl use in the "fentanyl era" using empirical purity data linked to self-reported consumption.
• Methodological Innovation: It demonstrates a robust statistical framework (bootstrapping with uncertainty propagation) to estimate dosage in an unregulated market where direct measurement is impossible.
• Clinical Benchmarking: It provides a data-driven baseline showing that typical illicit fentanyl consumption (~9,000 MME) is nearly 100 times higher than the 90 MME daily limit recommended for chronic pain and significantly higher than standard methadone maintenance doses (typically 80–180 MME).

5. Significance and Implications

Clinical Implications:

• MOUD Induction Challenges: The study suggests that the extreme difficulty in inducing patients onto methadone or buprenorphine is likely due to the massive gap between the MME of illicit fentanyl and standard treatment doses. A 180 mg methadone dose (approx. 846 MME) may represent only ~10% of a patient's daily illicit intake, leading to withdrawal and treatment failure.
• Treatment Strategy: The authors propose that clinicians may need to consider higher induction doses of methadone or "macrodosing" buprenorphine to match the physiological tolerance of patients, or utilize slow-release oral morphine to bridge the gap without QT prolongation risks.

Epidemiological Implications:

• Overdose Risk: The extreme variability in purity (0.23% to 38.80%) combined with high consumption volumes creates a "risk environment" where a single dose can vary wildly in potency, explaining the high rates of accidental overdose.
• Tolerance Escalation: The data supports the hypothesis that tolerance levels have escalated to unprecedented levels, making reversion to heroin or lower-potency opioids difficult for users.

Limitations:

• Sampling Bias: Data comes from a convenience sample of drug checking participants, who may represent a higher-acuity, high-volume user population compared to the general OUD population.
• Self-Report: Consumption quantities rely on self-reporting, which may be subject to recall bias.
• Correlation Uncertainty: The true relationship between purity and quantity consumed is unknown; the study uses a hybrid approach to mitigate this, but the exact correlation remains a variable.

Conclusion:
The study concludes that individuals consuming illicit fentanyl in Los Angeles are exposed to MME levels several orders of magnitude higher than clinical guidelines. This disparity is a likely driver of the current overdose crisis and the high failure rates of standard MOUD protocols, necessitating a re-evaluation of dosing strategies for OUD treatment in the fentanyl era.